29 Απρ EMA Recommends Restrictions on Protelos
Recommendation to restrict the use of Protelos/Osseor (strontium ranelate) CHMP confirms recommendation from the PRAC The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended a restriction in the use of the osteoporosis medicine Protelos/Osseor, following an assessment of data showing an increased risk of...